![]() ![]()
|
Bextra and the FDAConcern about Bextra stroke and heart attack risks first came to the fore of social concern after a similar drug was recalled because of its cardiovascular risks. Vioxx, also a COX-2 selective non-steroidal anti-inflammatory drug, was voluntarily pulled from the shelves by its maker in September 2004.
|
|||||||||||||||||||||||||||||||||||||